Literature DB >> 16821298

Prognostic significance of serum uric acid in acute myocardial infarction.

Michael L Tuck, Dalila B Corry.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 16821298     DOI： 10.1007/s11906-006-0004-0

Source DB:  PubMed          Journal:  Curr Hypertens Rep        ISSN： 1522-6417            Impact factor:   5.369


× No keyword cloud information.
  12 in total

1.  Plasma uric acid level and its association with diabetes mellitus and some biologic parameters in a biracial population of Fiji.

Authors:  J Tuomilehto; P Zimmet; E Wolf; R Taylor; P Ram; H King
Journal:  Am J Epidemiol       Date:  1988-02       Impact factor: 4.897

2.  Prognostic usefulness of serum uric acid after acute myocardial infarction (the Japanese Acute Coronary Syndrome Study).

Authors:  Sunao Kojima; Tomohiro Sakamoto; Masaharu Ishihara; Kazuo Kimura; Shunichi Miyazaki; Masakazu Yamagishi; Chuwa Tei; Hisatoyo Hiraoka; Masahiro Sonoda; Kazufumi Tsuchihashi; Nobuo Shimoyama; Takashi Honda; Yasuhiro Ogata; Kunihiko Matsui; Hisao Ogawa
Journal:  Am J Cardiol       Date:  2005-08-15       Impact factor: 2.778

3.  Uric acid predicts clinical outcomes in heart failure: insights regarding the role of xanthine oxidase and uric acid in disease pathophysiology.

Authors:  Joshua M Hare; Richard J Johnson
Journal:  Circulation       Date:  2003-04-22       Impact factor: 29.690

4.  Treatment of myocardial infarction in a coronary care unit. A two year experience with 250 patients.

Authors:  T Killip; J T Kimball
Journal:  Am J Cardiol       Date:  1967-10       Impact factor: 2.778

5.  Serum uric acid as an index of impaired oxidative metabolism in chronic heart failure.

Authors:  F Leyva; S Anker; J W Swan; I F Godsland; C S Wingrove; T P Chua; J C Stevenson; A J Coats
Journal:  Eur Heart J       Date:  1997-05       Impact factor: 29.983

6.  Effects of xanthine oxidase inhibition with allopurinol on endothelial function and peripheral blood flow in hyperuricemic patients with chronic heart failure: results from 2 placebo-controlled studies.

Authors:  Wolfram Doehner; Nina Schoene; Mathias Rauchhaus; Francisco Leyva-Leon; Darrell V Pavitt; David A Reaveley; Gerhard Schuler; Andrew J S Coats; Stefan D Anker; Rainer Hambrecht
Journal:  Circulation       Date:  2002-06-04       Impact factor: 29.690

7.  Allopurinol improves endothelial dysfunction in chronic heart failure.

Authors:  Colin A J Farquharson; Robert Butler; Alexander Hill; Jill J F Belch; Allan D Struthers
Journal:  Circulation       Date:  2002-07-09       Impact factor: 29.690

8.  Hypoxia injures endothelial cells by increasing endogenous xanthine oxidase activity.

Authors:  L S Terada; D M Guidot; J A Leff; I R Willingham; M E Hanley; D Piermattei; J E Repine
Journal:  Proc Natl Acad Sci U S A       Date:  1992-04-15       Impact factor: 11.205

9.  Effect of statins versus untreated dyslipidemia on serum uric acid levels in patients with coronary heart disease: a subgroup analysis of the GREek Atorvastatin and Coronary-heart-disease Evaluation (GREACE) study.

Authors:  Vasilios G Athyros; Moses Elisaf; Athanasios A Papageorgiou; Athanasios N Symeonidis; Anthimos N Pehlivanidis; Vasilios I Bouloukos; Haralambos J Milionis; Dimitri P Mikhailidis
Journal:  Am J Kidney Dis       Date:  2004-04       Impact factor: 8.860

10.  Hyperuricemia as a risk factor of coronary heart disease: The Framingham Study.

Authors:  F N Brand; D L McGee; W B Kannel; J Stokes; W P Castelli
Journal:  Am J Epidemiol       Date:  1985-01       Impact factor: 4.897
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.